Open-label Milnacipran for Persistent Knee Pain One Year After Total Knee Arthroplasty (TKA)
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The current study examines the effects of milnacipran in patients who have chronic persistent
knee pain one year or longer after total knee arthroplasty (TKA) to evaluate for a
pain-relieving effect.